Prognostic Value of Hemoglobin Concentration on Renal Outcomes with Diabetic Kidney Disease: A Retrospective Cohort Study
Xiaojie Chen,Jianteng Xie,Yifan Zhang,Shaogui Zhang,Sheng Li,Min Lu,Danfeng Liu,Weiting He,Hokhim Yau,Runli Jia,Yaxi Zhu,Wenjian Wang
DOI: https://doi.org/10.2147/dmso.s452280
2024-03-21
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Xiaojie Chen, 1, 2 Jianteng Xie, 2 Yifan Zhang, 2 Shaogui Zhang, 2 Sheng Li, 2 Min Lu, 2 Danfeng Liu, 2 Weiting He, 2 Hokhim Yau, 2 Runli Jia, 2 Yaxi Zhu, 2 Wenjian Wang 2 1 Department of Nephrology, the First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, Guangdong, People's Republic of China; 2 Department of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangdong, People's Republic of China Correspondence: Wenjian Wang, Department of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, 106 Zhongshan Er Road, Main Building, Room 1436, Guangzhou, Guangdong, 510080, People's Republic of China, Tel +86 (20)83827812-61421, Email Objective: Diabetic kidney disease (DKD) patients with anemia face an elevated risk of glomerular filtration rate decline. However, the association between hemoglobin and estimated Glomerular Filtration Rate (eGFR) progression remains to be elucidated. Methods: A retrospective cohort of 815 subjects with DKD was followed from January 2010 to January 2023. A Cox proportional hazard regression model was utilized to explore the predictive role of hemoglobin in renal outcomes. Renal outcomes were defined as a composite endpoint, including a 50% decline in eGFR from baseline or progression to End-Stage Renal Disease (ESRD). To unveil any nonlinear relationship between hemoglobin and renal outcomes, Cox proportional hazard regression with cubic spline functions and smooth curve fitting was conducted. Additionally, subgroup analyses were performed to identify specific patient populations that might derive greater benefits from higher hemoglobin. Results: Among the 815 DKD subjects, the mean age was 56.482 ± 9.924 years old, and 533 (65.4%) were male. The mean hemoglobin was 121.521± 22.960 g/L. The median follow-up time was 21.103± 18.335 months. A total of 182 (22.33%) individuals reached the renal composite endpoint during the study period. After adjusting for covariates, hemoglobin was found to exert a negative impact on the renal composite endpoint in patients with DKD (HR 0.975, 95% CI [0.966, 0.984]). A nonlinear relationship between hemoglobin and the renal composite endpoint was identified with an inflection point at 109 g/L. Subgroup analysis unveiled a more pronounced association between hemoglobin and renal prognosis in males. Conclusion: Hemoglobin emerges as a predictive indicator for the renal prognosis of diabetic kidney disease in China. This study reveals a negative and non-linear relationship between hemoglobin levels and the renal composite endpoint. A substantial association is noted when hemoglobin surpasses 109 g/L in relation to the renal composite endpoint. Keywords: hemoglobin, eGFR decline, ESRD, diabetic kidney disease, non-linear, Cox proportional-hazards regression Diabetic kidney disease (DKD) is the most common cause of end-stage renal disease (ESRD). 1 Early detection and improved management may slow down the progression of renal function and reduce its complications. However, prediction factors of DKD progression are not fully understood. Anemia is a major complication resulting from chronic kidney disease (CKD) and also a risk factor for cardiovascular events and eGFR decline. In a Chinese cross-sectional study, low eGFR (<60mL/min/1.73m 2 ) were associated with SBP, retinopathy, TC, TG, and anemia. 2 A study with 526 patients with type 2 diabetes during the follow-up period showed that anemia was an independent risk factor for rapid eGFR decline. 3 In another study, which included a total of 160,031 patients, anemia was a risk factor associated with adverse chronic renal outcomes. 4 According to a predicted model, when adding the risk factor of anemia to the conventional factors, it revealed the predictive performance of severe interstitial fibrosis and tubular atrophy (IF/TA) in DKD was improved, 5 also in severe IFTA, lower Hb level was associated with a higher risk of death. 6 Early identification and treatment of anemia have been shown to slow renal progression and delay renal replacement therapy in non-dialysis CKD patients. It also improves cardiac function, reducing hospitalization and mortality rates. In a multi-center study conducted in China, anemia was present in 51.5% of patients with CKD who were not undergoing dialysis, and the prevalence was higher in patients with diabetic nephropathy (DN) (68.0%) than in patients with hypertensive renal damage (56.6%) or chr -Abstract Truncated-
endocrinology & metabolism